FEINBERG LARRY N
SC 13G/A, 1999-02-12
Previous: SOLOMON PAGE GROUP LTD, 10-Q, 1999-02-12
Next: FEINBERG LARRY N, SC 13G/A, 1999-02-12












UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934

Amendment No.:  1

Name of Issuer:  Somnus Medical Technologies, Inc.

Title of Class of Securities: Common Stock

CUSIP Number:  835397100



  (Date of Event Which Requires Filing of this Statement)

                     December 31, 1998

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of
Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).





<PAGE>


CUSIP Number: 835397100

1.  Name of Reporting Person
    I.R.S. Identification No. of Above Person

         Larry N. Feinberg
         

2.  Check the Appropriate Box if a Member of a Group

         a.   
         b.   

3.  SEC Use Only


4.  Citizenship or Place of Organization

         United States

Number of Shares Beneficially Owned by Each Reporting Person
With:

5.  Sole Voting Power:

         1,041,001

6.  Shared Voting Power:

         


7.  Sole Dispositive Power:

         1,041,001

8.  Shared Dispositive Power:

         

9.  Aggregate Amount Beneficially Owned by Each Reporting
    Person

         1,041,001

10. Check Box if the Aggregate Amount in Row (9) Excludes Certain
    Shares




                             2





<PAGE>


11. Percent of Class Represented by Amount in Row (9)

          7.55%

12. Type of Reporting Person

          IN












































                             3





<PAGE>


Item 1(a) Name of Issuer:  Somnus Medical Technologies, Inc.

      (b) Address of Issuer's Principal Executive Offices:

          285 N. Wolfe Road
          Sunnyvale, California 94086

Item 2(a) - (c).  Name, Principal Business Address, and
Citizenship of Persons Filing:

          Larry N. Feinberg - United States citizen
          c/o Oracle Investment Management, Inc.
          712 Fifth Avenue
          45th Floor
          New York, New York 10019

    (d)   Title of Class of Securities:  Common Stock

    (e)   CUSIP Number:  835397100

Item 3.  If this statement is filed pursuant to Rule 13d-1(b)(1)
or 13d-2(b) or (c) check whether the person filing is:

    (a)  / / Broker or dealer registered under Section 15 of the
             Act,

    (b)  / / Bank as defined in Section 3(a)(6) of the Act,

    (c)  / / Insurance Company as defined in Section 3(a)(19) of
             the Act,

    (d)  / / Investment Company registered under Section 8 of the
             Investment Company Act,

    (e)  / / Investment Adviser registered under Section 203 of
             the Investment Advisers Act of 1940,

    (f)  / / Employee Benefit Plan, Pension Fund which is subject
             to the provisions of the Employee Retirement Income
             Security Act of 1974 or Endowment Fund,

    (g)  / / Parent Holding Company, in accordance with Rule 13d-
             1(b)(ii)(G),

    (h)  / / Savings association as defined in Section 3(b) of
             the Federal Deposit Insurance Act,





                             4





<PAGE>


    (i)  / / Church plan excluded from the definition of an
             investment company under Section 3(c)(14) of the
             Investment Company Act,

    (j)  / / Group, in accordance with Rule 13d-1(b)(1)(ii)(H).

If this statement is filed pursuant to Rule 13d-1(c), check this
box. /X/

 Item 4. Ownership.
         
         (a) Amount Beneficially Owned:  1,041,001

         (b) Percent of Class:  7.55%

         (c) 0 shares with shared power to vote or to direct the
             vote; 1,041,001 shares with sole power to vote or to
             direct the vote; 0 shares with shared power to
             dispose or to direct the disposition of; 1,041,001
             shares with the sole power to dispose or to direct
             the disposition of

Item 5.  Ownership of Five Percent or Less of a Class.

         N/A

Item 6.  Ownership of More than Five Percent on Behalf of Another
         Person.

         N/A

Item 7.  Identification and Classification of the Subsidiary
         Which Acquired the Security Being Reported by the Parent
         Holding Company.
    
         N/A

Item 8.  Identification and Classification of Members of the
         Group.
    
         N/A

Item 9.  Notice of Dissolution of the Group.
    
         N/A






                             5





<PAGE>


Item 10.

    Certification for Rule 13d-1(c): By signing below I certify
that, to the best of my knowledge and belief, the securities
referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any
transaction having that purpose or effect.

         After reasonable inquiry and to the best of my knowledge
         and belief, I certify that the information set forth in
         this statement is true, complete and correct.



    /s/ Larry N. Feinberg                   
    _________________________               
    Larry N. Feinberg                       
   
    February 11, 1999
    __________________
    Date




























                                6
00751001.BA4



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission